Teladoc Health (TDOC) Stock Price

Teladoc Health Price

NASDAQ·CLOSED
6.68USD-0.23 (-3.38 %)
Market closed

Over the last 12 years Teladoc Health grew revenue by 49.7% annually, reaching 2.53 B USD. For Teladoc Health, the net margin of -7.9% is up versus -21.1% a few years ago. At today's price the dividend yield works out to roughly 0.52%. The consensus 12-month price target for Teladoc Health is 8.42 USD, about 26.0% above where the stock trades today. Of 34 analysts, 10 rate the stock a buy — an overall Hold consensus. The stock trades about 49% above its 52-week low.

Teladoc Health stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Teladoc Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Teladoc Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Teladoc Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Teladoc Health Stock Price History
DateTeladoc Health Price
8/6/20266.68 USD
8/5/20266.91 USD
8/4/20266.49 USD
8/3/20266.68 USD
7/31/20266.71 USD
7/30/20266.58 USD
7/29/20269.31 USD
7/27/20268.86 USD
7/23/20268.66 USD
7/22/20268.92 USD
7/21/20269.71 USD
7/20/20269.65 USD
7/17/20269.43 USD
7/16/20269.47 USD
7/15/20269.72 USD
7/14/20269.27 USD
7/13/20269.39 USD
7/10/20269.28 USD
7/9/20269.21 USD
7/8/20269.23 USD
7/7/20269.52 USD
7/6/20269.18 USD
7/2/20269.20 USD
7/1/20269.10 USD
6/30/20268.48 USD
6/29/20268.60 USD
6/26/20268.39 USD
6/25/20267.91 USD
6/24/20267.81 USD
6/23/20267.69 USD
6/22/20267.82 USD
6/18/20267.78 USD
6/17/20267.64 USD
6/16/20267.51 USD
6/15/20267.66 USD
6/12/20267.18 USD
6/11/20267.09 USD
6/10/20267.07 USD
6/9/20266.93 USD
6/8/20267.08 USD
6/5/20267.06 USD
6/4/20267.34 USD
6/3/20267.16 USD
6/2/20267.68 USD
6/1/20267.85 USD
5/29/20267.89 USD
5/28/20267.13 USD
5/27/20266.66 USD
5/26/20266.68 USD
5/22/20266.57 USD
5/21/20266.39 USD
5/20/20266.42 USD
5/19/20266.61 USD
5/18/20266.35 USD
5/15/20266.36 USD
5/14/20266.61 USD
5/13/20266.79 USD
5/12/20266.77 USD
5/11/20266.92 USD
5/8/20267.25 USD
5/7/20266.96 USD
5/6/20266.80 USD
5/5/20266.66 USD
5/4/20266.63 USD
5/1/20266.46 USD
4/30/20266.06 USD
4/29/20265.95 USD
4/28/20266.00 USD
4/27/20265.85 USD
4/24/20265.75 USD
4/23/20265.81 USD
4/22/20265.92 USD
4/21/20266.00 USD
4/20/20266.10 USD
4/17/20265.69 USD
4/16/20265.82 USD
4/15/20265.54 USD
4/14/20265.24 USD
4/13/20265.22 USD
4/10/20265.10 USD
4/9/20265.25 USD
4/8/20265.27 USD
4/7/20265.32 USD
4/6/20265.32 USD
4/2/20265.27 USD
4/1/20265.28 USD
3/31/20265.45 USD
3/30/20265.14 USD
3/27/20265.14 USD
3/26/20265.52 USD
3/25/20265.57 USD
3/24/20265.42 USD
3/23/20265.48 USD
3/20/20265.35 USD
3/19/20265.52 USD
3/18/20265.42 USD
3/17/20265.61 USD
3/16/20265.39 USD
3/13/20265.37 USD
3/12/20265.36 USD
3/11/20265.47 USD
3/10/20265.57 USD
3/9/20265.30 USD
3/6/20265.08 USD
3/5/20265.12 USD
3/4/20265.13 USD
3/3/20265.10 USD
3/2/20265.16 USD
2/27/20265.26 USD
2/26/20265.35 USD
2/25/20264.65 USD
2/24/20264.54 USD
2/23/20264.56 USD
2/20/20264.74 USD
2/19/20264.88 USD
2/18/20264.66 USD
2/17/20264.56 USD
2/13/20264.65 USD
2/12/20264.47 USD
2/11/20264.68 USD
2/10/20264.85 USD
2/9/20264.98 USD
2/6/20265.01 USD
2/5/20264.73 USD
2/4/20264.91 USD
2/3/20265.11 USD
2/2/20265.37 USD
1/30/20265.45 USD
1/29/20265.70 USD
1/28/20265.74 USD
1/27/20265.91 USD
1/26/20266.29 USD
1/23/20266.33 USD
1/22/20266.35 USD
1/21/20266.16 USD
1/20/20266.07 USD
1/16/20266.28 USD
1/15/20266.53 USD
1/14/20266.61 USD
1/13/20266.99 USD
1/12/20267.25 USD
1/9/20267.46 USD
1/8/20267.61 USD
1/7/20267.57 USD
1/6/20268.00 USD
1/5/20267.28 USD
1/2/20267.05 USD
12/31/20257.00 USD
12/30/20257.00 USD
12/29/20256.93 USD
12/26/20257.12 USD
12/24/20257.25 USD
12/23/20257.21 USD
12/22/20257.26 USD
12/19/20257.23 USD
12/18/20257.14 USD
12/17/20257.25 USD
12/16/20257.41 USD
12/15/20257.34 USD
12/12/20257.55 USD
12/11/20257.62 USD
12/10/20257.69 USD
12/9/20257.70 USD
12/8/20257.56 USD
12/5/20257.59 USD
12/4/20257.78 USD
12/3/20257.53 USD
12/2/20257.50 USD
12/1/20257.44 USD
11/28/20257.59 USD
11/26/20257.45 USD
11/25/20257.46 USD
11/24/20257.25 USD
11/21/20256.96 USD
11/20/20256.76 USD
11/19/20257.05 USD
11/18/20257.00 USD
11/17/20256.75 USD
11/14/20256.92 USD
11/13/20257.07 USD
11/12/20257.47 USD
11/11/20257.56 USD
11/10/20257.50 USD
11/7/20257.53 USD
11/6/20257.62 USD
11/5/20258.06 USD
11/4/20257.98 USD
11/3/20258.14 USD
10/31/20258.63 USD
10/30/20258.74 USD
10/29/20258.23 USD
10/28/20258.36 USD
10/27/20259.01 USD
10/24/20259.46 USD
10/23/20258.60 USD
10/22/20258.34 USD
10/21/20258.66 USD
10/20/20258.98 USD
10/17/20258.53 USD
10/16/20259.02 USD
10/15/20258.94 USD
10/14/20258.93 USD
10/13/20258.25 USD
10/10/20258.00 USD
10/9/20258.85 USD
10/8/20259.09 USD
10/7/20258.37 USD
10/6/20258.57 USD
10/3/20259.01 USD
10/2/20258.48 USD
10/1/20257.80 USD
9/30/20257.73 USD
9/29/20258.20 USD
9/26/20258.16 USD
9/25/20257.95 USD
9/24/20258.40 USD
9/23/20258.37 USD
9/22/20258.19 USD
9/19/20257.95 USD
9/18/20258.26 USD
9/17/20257.90 USD
9/16/20257.87 USD
9/15/20257.67 USD
9/12/20257.68 USD
9/11/20257.77 USD
9/10/20257.49 USD
9/9/20257.80 USD
9/8/20257.84 USD
9/5/20257.82 USD
9/4/20257.63 USD
9/3/20257.76 USD
9/2/20257.64 USD
8/29/20257.73 USD
8/28/20257.89 USD
8/27/20257.74 USD
8/26/20257.81 USD
8/25/20257.67 USD
8/22/20257.68 USD
8/21/20257.19 USD
8/20/20257.22 USD
8/19/20257.34 USD
8/18/20257.49 USD
8/15/20257.52 USD
8/14/20257.30 USD
8/13/20257.44 USD
8/12/20256.87 USD
8/11/20256.78 USD
Access this data via the Eulerpool API
Get Free API Key

Teladoc Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
2.60 B USD
-248.55 M USD
-220.37 M USD
Jan 1, 2024
2.57 B USD
-1.02 B USD
-1.00 B USD
Jan 1, 2025
2.53 B USD
-262.96 M USD
-200.32 M USD
Jan 1, 2026 (e)
2.51 B USD
-124.27 M USD
-161.54 M USD
Jan 1, 2027 (e)
2.54 B USD
-125.85 M USD
-113.06 M USD
Jan 1, 2028 (e)
2.57 B USD
-127.52 M USD
-80.63 M USD
Jan 1, 2029 (e)
2.64 B USD
-130.74 M USD
-34.10 M USD
Jan 1, 2030 (e)
2.83 B USD
-140.10 M USD
27.49 M USD

Teladoc Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 9, 2026, 9:24 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
0.080.120.230.420.551.092.032.412.602.572.532.512.542.572.642.83
79.0759.7489.4378.9732.6197.6585.9118.418.15-1.27-1.56-0.871.281.342.537.13
72.7373.9873.3969.3066.5564.3268.0169.0870.7970.7769.5169.5169.5169.5169.5169.51
0.060.090.170.290.370.701.381.661.841.821.761.741.761.791.831.96
-0.06-0.05-0.08-0.07-0.08-0.42-0.24-13.65-0.25-1.02-0.26-0.12-0.13-0.13-0.13-0.14
-71.43-42.28-32.19-15.59-14.47-38.24-11.71-567.50-9.53-39.70-10.36-4.95-4.92-4.94-4.93-4.95
-0.06-0.07-0.11-0.10-0.10-0.49-0.43-13.66-0.22-1.00-0.20-0.16-0.11-0.08-0.030.03
241.1827.5943.24-8.491.03394.90-11.753,091.36-98.39355.00-80.02-19.50-29.81-29.20-57.50-179.41
38.4652.1958.3770.2472.56128.30159.94162.17166.06172.77176.22176.22176.22176.22176.22176.22
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Teladoc Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Teladoc Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Teladoc Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Teladoc Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Teladoc Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Teladoc Health stock margins

The Teladoc Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Teladoc Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Teladoc Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
68.01 %
-11.76 %
-21.09 %
Jan 1, 2022
69.09 %
-567.30 %
-567.53 %
Jan 1, 2023
70.80 %
-9.55 %
-8.47 %
Jan 1, 2024
70.76 %
-39.73 %
-38.97 %
Jan 1, 2025
69.50 %
-10.39 %
-7.92 %
Jan 1, 2026 (e)
69.50 %
-4.96 %
-6.44 %
Jan 1, 2027 (e)
69.50 %
-4.96 %
-4.45 %
Jan 1, 2028 (e)
69.50 %
-4.96 %
-3.13 %

Teladoc Health Stock Revenue, EBIT, Earnings per Share

The Teladoc Health earnings per share therefore indicates how much revenue Teladoc Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
12.71 USD
-1.49 USD
-2.68 USD
Jan 1, 2022
14.84 USD
-84.20 USD
-84.23 USD
Jan 1, 2023
15.67 USD
-1.50 USD
-1.33 USD
Jan 1, 2024
14.87 USD
-5.91 USD
-5.80 USD
Jan 1, 2025
14.36 USD
-1.49 USD
-1.14 USD
Jan 1, 2026 (e)
14.14 USD
-0.71 USD
-0.91 USD
Jan 1, 2027 (e)
14.32 USD
-0.71 USD
-0.64 USD
Jan 1, 2028 (e)
14.51 USD
-0.72 USD
-0.45 USD

Teladoc Health business model & stock analysis

Teladoc Health Inc is a leading global company in the field of telemedicine. Founded in 2002, Teladoc Health Inc has since grown and achieved a revenue of $1.1 billion in 2020. The company is headquartered in New York City and employs over 2,300 employees worldwide. As a pioneer in the field of telemedicine, Teladoc Health Inc offers fast and easy access to medical care via telephone, video, or app. This is particularly important in rural areas and for people with limited access to medical facilities. The company works closely with insurance companies, employers, and healthcare providers to ensure high-quality medical care worldwide. Teladoc Health Inc's business model is based on subscription fees and fees for individual consultations. The company works with over 50,000 licensed healthcare providers, including doctors, therapists, psychologists, and specialists, to provide medical consultations and virtual visits. Telemedicine offers a diverse range of services, including general medical advice, specialist consultations, mental health care, chronic disease management, and virtual meetings on health risks. The services are offered globally and are among the most well-known in the industry. Teladoc Health Inc has several divisions specialized in different areas of healthcare, including: - Teladoc: offers general medical advice and a 24/7 emergency service for patients. - BetterHelp: provides a wide range of therapy options for psychological health issues, including counseling sessions with licensed therapists. - HealthiestYou: specializes in counseling on patients' health risks and provides assistance for chronic diseases and allergy management. - Best Doctors: focuses on specialist consultations for acute illnesses and offers expert evaluations and second opinions for complex medical questions. - Advance Medical: this service is primarily intended for employers and insurance companies and provides a range of options for medical support for new employees. One of Teladoc Health Inc's most innovative products is the "Teladoc Mobile App," which is considered one of the leading telemedicine apps on the market. This app is fast, easy to use, and offers a variety of telemedicine services, including a virtual waiting room feature, a secure messaging platform, and a health risk checklist. Users can register for free for the first time and immediately test the service in their relationship. Overall, Teladoc Health Inc has the potential to revolutionize an established industry. The company offers a faster and more convenient way of providing medical care to patients while also focusing on a service of the highest quality. With the changing healthcare structure in many countries towards telemedicine services, there is therefore great potential for Teladoc Health Inc to continue to grow in the field of digital health care.

Teladoc Health SWOT Analysis

Strengths

Teladoc Health Inc has a strong market presence and brand recognition, being one of the leading telehealth companies globally.

The company offers a wide range of virtual healthcare services, including remote consultations, digital health records, and remote monitoring, enabling patients to access care conveniently.

Teladoc Health's comprehensive platform supports multiple languages and is accessible via various devices, ensuring accessibility to a diverse user base.

Weaknesses

One of the challenges for Teladoc Health Inc is the heavy reliance on internet connectivity, which can impose limitations in areas with poor internet infrastructure, hindering access to their services.

The company faces strong competition from other telehealth providers, making it crucial to continuously innovate and differentiate their offerings to retain market share.

Opportunities

The COVID-19 pandemic has accelerated the adoption of telehealth services globally, presenting Teladoc Health Inc with significant growth opportunities as more individuals and healthcare providers recognize the benefits of virtual care.

Expansion into new markets and strategic partnerships with healthcare systems, insurers, and employers can broaden Teladoc Health's customer base and enhance its market position.

Threats

Regulations and legal barriers in certain regions can pose challenges for Teladoc Health Inc's expansion plans and operating practices.

The emergence of new competitors and advancements in technology may disrupt the telehealth market and threaten Teladoc Health's competitive advantage.

Teladoc Health Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Teladoc Health Employees
Details
Date
Teladoc Health Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Teladoc Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Teladoc Health historical P/E ratio, EBIT multiple, and P/S ratio

Teladoc Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Teladoc Health shares outstanding

The number of shares of Teladoc Health was 176.22 M in 2025. This indicates how many shares Teladoc Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
159.94 M Stocks
Jan 1, 2022
162.17 M Stocks
Jan 1, 2023
166.06 M Stocks
Jan 1, 2024
172.77 M Stocks
Jan 1, 2025
176.22 M Stocks
Jan 1, 2026 (e)
176.22 M Stocks
Jan 1, 2027 (e)
176.22 M Stocks
Jan 1, 2028 (e)
176.22 M Stocks

Teladoc Health Dividend History

1 years of dividend payments

YearAnnual DividendYoY ChangePayments
20210.04USD—1×

Teladoc Health dividend payout ratio

In 2025, Teladoc Health had a payout ratio of 0.00%. The payout ratio indicates the percentage of the company's profits that Teladoc Health distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
-1.31 %
Jan 1, 2022
0.00 %
Jan 1, 2023
0.00 %
Jan 1, 2024
0.00 %
Jan 1, 2025
0.00 %
Jan 1, 2026 (e)
0.00 %
Jan 1, 2027 (e)
0.00 %
Jan 1, 2028 (e)
0.00 %

Current Teladoc Health forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
2.94 %
Buy
29.41 % (10)
Hold
70.59 % (24)
Sell
0.00 % (0)
12M Price Target
8.42
Last Price
7.13
Currency
USD
12M Return Potential
18.02 %
LTM Return
0 %

Teladoc Health Analyst Rating Actions

DateFirmActionRatingReliability
7/30/2026
Evercore ISI Group
Evercore ISI Group
MaintainedIn Line62
7/30/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy59
7/21/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy59
7/7/2026
B of A Securities
B of A Securities
MaintainedBuy70
5/5/2026
Citigroup
Citigroup
MaintainedNeutral48
4/8/2026
Evercore ISI Group
Evercore ISI Group
MaintainedIn Line62
3/26/2026
Barclays
Barclays
MaintainedEqual Weight33
3/13/2026
JP Morgan
JP Morgan
MaintainedNeutral80
3/10/2026
Deutsche Bank
Deutsche Bank
UpgradeHoldBuy–
3/3/2026
Oppenheimer
Oppenheimer
MaintainedOutperform65

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Teladoc Health Earnings Calls

2025

Teladoc Health Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
7/28/2026-0.25USD-627.21 MUSD-2026 Q2
4/29/2026-0.32USD-625.56 MUSD-2026 Q1
2/25/2026-0.19USD-647.94 MUSD-2025 Q4
4/24/2024-0.43USD-685.52 MUSD-2024 Q1
2/20/2024-0.21USD-684.79 MUSD-2023 Q4
7/25/2023-0.39USD-680.30 MUSD-2023 Q2
4/25/2023-0.41USD-662.85 MUSD-2023 Q1
2/20/2023-0.25USD-640.27 MUSD-2022 Q4
10/26/2022-0.58USD-619.16 MUSD-2022 Q3
7/27/2022-0.66USD-592.52 MUSD-2022 Q2

EESG©

Eulerpool ESG Scorecard© for the Teladoc Health stock

36/100
1
Environment
27
Social
80
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Teladoc Health shareholder structure

% Name
8.23995%
BLACKROCK, INC.
BLACKROCK, INC.
6.93267%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.55909%
RENAISSANCE TECHNOLOGIES LLC
RENAISSANCE TECHNOLOGIES LLC
4.43032%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
4.35382%
POINT72 ASSET MANAGEMENT, L.P.
POINT72 ASSET MANAGEMENT, L.P.
3.55140%
DIMENSIONAL FUND ADVISORS LP
DIMENSIONAL FUND ADVISORS LP
...

Teladoc Health Beneficial Ownership Filings (SEC 13D/G)

Free Float
100.0%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
13.00%
of 9 Pages
of 9 Pages
SEC ↗
12.60%
Trident Capital Management-VI, L.L.C.
Trident Capital Management-VI, L.L.C.
SEC ↗
12.10%
Trident Capital Fund-VI, L.P.
Trident Capital Fund-VI, L.P.
SEC ↗
11.00%
Baillie Gifford & Co (Scottish partnership)
Baillie Gifford & Co (Scottish partnership)
SEC ↗
10.60%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
9.00%
Tiger Global Performance, LLC
Tiger Global Performance, LLC
SEC ↗
9.00%
Tiger Global Management, LLC
Tiger Global Management, LLC
SEC ↗
9.00%
Scott Shleifer
Scott Shleifer
SEC ↗
9.00%
Charles P. Coleman III
Charles P. Coleman III
SEC ↗
7.92%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗

Teladoc Health Executives and Management Board

15 members · avg. age 62 · 27 % women

CD

Mr. Charles Divita (55)

Chief Executive Officer, Director · since 2024

16.06 M USD

Management

MM

Ms. Mala Murthy (61)

Chief Financial Officer · since 2024

5.23 M USD
CN

Mr. Carlos Nueno (51)

President, International

2.74 M USD
AV

Mr. Adam Vandervoort (50)

Chief Legal Officer, Secretary

2.63 M USD
KB

Ms. Kelly Bliss (50)

President, U.S. Group Health

2.51 M USD
FM

Mr. Fernando Madeira (55)

President of BetterHelp

–
PF

Mr. Patrick Feeley

Vice President - Investor Relations · since 2021

–

Board of Directors

DS

Mr. David Snow (70)

Independent Chairman of the Board

307,497.00 USD
DS

Mr. David Shedlarz (76)

Independent Director

272,497.00 USD
JE

Mr. J. Eric Evans (48)

Independent Director

266,096.00 USD
TM

Mr. Thomas Mckinley (73)

Independent Director

263,486.00 USD
KP

Mr. Kenneth Paulus (65)

Independent Director

259,997.00 USD
MS

Dr. Mark Smith (73)

Independent Director

259,997.00 USD

Teladoc Health Supply Chain

Teladoc Health Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
9 companies
#Nameβ 1YTrend
1
Phreesia
Supplier·Health Care Technology·US
0.56
0.79
0.94
0.93
0.95
0.36
—
2
Dell Technolges C
Supplier·Customer·Technology Hardware, Storage & Peripherals·US
0.06
0.52
0.73
0.76
0.86
0.30
0.79
#Nameβ 1YTrend
1
Castlight Health, Inc.
Supplier·Customer·Health Care Technology·US
-0.22
-0.16
-0.71
-0.49
0.13
—
—
2
Microsoft
Supplier·Customer·Software·US
0.33
0.28
0.52
0.80
-0.31
-0.81
-0.18
3
Alphabet A
Supplier·Customer·Interactive Media & Services·US
-0.17
0.54
0.73
0.82
-0.05
-0.79
-0.03
4
DexCom
Supplier·Customer·Health Care Equipment & Supplies·US
0.77
0.78
0.89
0.84
0.53
-0.31
—
5
Amazon.com
Supplier·Internet & Direct Marketing Retail·US
-0.04
0.42
0.51
0.73
0.64
0
0.45

Frequently asked questions about Teladoc Health

The business model of Teladoc Health Inc focuses on providing telehealth services and virtual healthcare solutions. The company operates a digital platform that connects patients with healthcare providers remotely, enabling individuals to access convenient and timely medical consultations. Teladoc Health Inc's platform offers a range of services, including video visits, online messaging, and phone consultations, allowing patients to receive expert medical advice, diagnoses, prescriptions, and ongoing care from licensed doctors and healthcare professionals. This model allows Teladoc Health Inc to deliver accessible, cost-effective, and scalable healthcare services, catering to the needs of patients in various locations and improving overall healthcare outcomes.

Teladoc Health Inc is primarily active in the healthcare industry.

The main competitors of Teladoc Health Inc in the market are Amwell, Doctor On Demand, and MDLIVE.

Teladoc Health Inc is a renowned telehealth company that provides virtual healthcare services. Founded in 2002, Teladoc has emerged as a leader in the healthcare industry, revolutionizing patient care through technology. With a vision to improve access to medical care, Teladoc offers convenient and remote consultations with licensed doctors via phone or video. Over the years, Teladoc has garnered a strong reputation for its reliable, secure, and efficient healthcare platform. As a company focused on enhancing patient experiences and outcomes, Teladoc Health Inc has expanded its services globally, connecting patients with trusted healthcare professionals anytime, anywhere.

Teladoc Health Inc, a leading telemedicine company, has achieved several significant milestones. One noteworthy accomplishment is its acquisition of Best Doctors, a global expert medical opinion provider. This acquisition helped Teladoc Health expand its services and expertise in offering virtual healthcare solutions. Additionally, the company established strategic partnerships with major healthcare organizations, including Aetna and CVS Health, further increasing its reach and market presence. Teladoc Health Inc also achieved impressive financial growth, with its revenue consistently growing year over year. These milestones demonstrate Teladoc Health Inc's commitment to innovation, collaboration, and delivering quality telehealth services worldwide.

Teladoc Health Inc is primarily present in numerous countries and regions across the globe. Its telehealth services are widely available to individuals residing in the United States, Canada, United Kingdom, Australia, and Spain, among others. With a significant presence in these key markets, Teladoc Health Inc offers accessible and convenient virtual healthcare solutions to individuals seeking medical consultations and support remotely. With its advanced technology and network of licensed healthcare professionals, Teladoc Health Inc is dedicated to improving healthcare access and quality across borders, providing valuable medical services to patients regardless of their location.

Teladoc Health Inc represents a values-driven corporate philosophy that focuses on providing accessible and affordable healthcare through telemedicine services. With a commitment to quality care and patient satisfaction, Teladoc Health prioritizes innovation, technological advancement, and convenient access to medical professionals. By utilizing virtual visits and digital health technologies, Teladoc Health aims to improve healthcare outcomes and enhance the overall patient experience. With a strong emphasis on patient-centric care, Teladoc Health is dedicated to ensuring the well-being and accessibility of healthcare for individuals and communities worldwide.

Analysts currently set an average price target of 8.88 USD for the Teladoc Health stock (median: 8.42 USD), implying +24.5 % versus the latest price. The consensus is based on 34 analyst ratings.

Teladoc Health Analyst Price Targets 2026

34 analysts currently rate the Teladoc Health stock: 10 recommend buying, 24 holding and 0 selling. For 2026, analysts expect Teladoc Health to generate revenue of 2.51 B USD and earnings per share of -0.92 USD.

Teladoc Health Analyst Price Targets 2026

Converted at the current exchange rate, the Teladoc Health share trades at 5.78 EUR (6.68 USD).

The Teladoc Health share (TDOC) is listed on 11 stock exchanges, including: NYSE (TDOC), NASDAQ (TDOC), XETRA (4LL.DE), Frankfurt (4LL.F), München (4LL.MU), Stuttgart (4LL.SG), Düsseldorf (4LL.DU), Berlin (4LL.BE).

Teladoc Health Inc is an American company known for its online healthcare services. The company's business model includes various divisions and products that enable customers to easily access a variety of healthcare services. Teladoc Health Inc's main division is its virtual doctor visit platform, which allows patients to connect with a licensed doctor or other qualified professional without having to leave their homes. The platform offers a wide range of healthcare services such as medical advice or diagnosis, counseling by psychologists and therapists, skincare and dermatology advice, as well as support for chronic conditions like diabetes or hypertension. In addition to virtual doctor visits, Teladoc Health Inc also offers a telemedicine monitoring program that allows customers to monitor vital signs such as blood pressure, blood sugar, or weight at home. The data is sent in real-time to the doctor, who can then provide appropriate recommendations. Teladoc Health Inc also has a platform for virtual therapy and psychological counseling, which allows patients to speak with a licensed therapist or psychologist in a secure environment. The platform is easy to use and provides customers with an anonymous method to seek help for mental health issues. Another offering from Teladoc Health Inc is an employee health program that allows companies to provide their employees with access to medical professionals and health navigation services. By collaborating with employers, the company can provide a cost-effective solution for employee education and counseling to improve their health and well-being. Teladoc Health Inc's business model is based on utilizing technology to facilitate access to healthcare services for customers. By offering a variety of services focused on virtual visits, monitoring, and therapy, the company can meet customers' needs and grow. In summary, Teladoc Health Inc is a company that provides a variety of healthcare services to customers through the use of technology. Its various divisions offer access to medical advice and diagnosis, telemedicine monitoring, psychological counseling, and employee benefits for companies. By effectively utilizing technology, the company can offer easily accessible and cost-effective solutions for customers, ultimately leading to better quality of life and health. Teladoc Health Inc provides a variety of online healthcare services to customers. Some of its main divisions include a virtual doctor visit platform, telemedicine monitoring program, a platform for virtual therapy and psychological counseling, and an employee health program for companies. The company's business model focuses on utilizing technology to make healthcare services easily accessible and cost-effective.

The expected revenue of Teladoc Health is 2.51 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Teladoc Health is -161.54 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Teladoc Health is currently -7.29. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Teladoc Health stock.

The price-to-sales ratio (P/S) of Teladoc Health is currently 0.47. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Teladoc Health stock.

The Eulerpool Quality Score for Teladoc Health is 3/10.

The ISIN of Teladoc Health is US87918A1051. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Teladoc Health is A14VPK. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Teladoc Health is TDOC. The ticker symbol is used to trade Teladoc Health shares on the stock exchange.

The current dividend yield of Teladoc Health is 0.52 %.

Teladoc Health paid dividends every year for the past 0 years.

Teladoc Health is assigned to the 'Health' sector.

To receive the latest dividend of Teladoc Health from amounting to 0.04 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of Teladoc Health are distributed in USD.

All fundamentals and in-depth analysis of Teladoc Health

Our stock analysis for Teladoc Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Teladoc Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Teladoc Health Stock
Teladoc Health Revenue→
Teladoc Health Stock
Teladoc Health Net Income→
Teladoc Health Stock
Teladoc Health P/E→
Teladoc Health Stock
Teladoc Health P/S→
Teladoc Health Stock
Teladoc Health EBIT→
Teladoc Health Stock
Teladoc Health Dividend→
Teladoc Health Stock
Teladoc Health Directors Dealings→
Teladoc Health Stock
Teladoc Health Stocks→
Teladoc Health Stock
Teladoc Health Market capitalization→
Teladoc Health Stock
Teladoc Health Debt→
Teladoc Health Stock
Teladoc Health Liabilities→
Teladoc Health Stock
Teladoc Health Equity→
Teladoc Health Stock
Teladoc Health AAQS→
Teladoc Health Stock
Teladoc Health Employees→
Teladoc Health Stock
Teladoc Health ROE→
Teladoc Health Stock
Teladoc Health ROA→
Teladoc Health Stock
Teladoc Health ROCE→
Teladoc Health Stock
Teladoc Health News→
Teladoc Health Stock
Teladoc Health Analyst Price Targets→

Health Stocks

TeleflexTELA BioTelix Pharmaceuticals LimitedTejnaksh HealthcareTellgenTego ScienceTelo GenomicsTectonic TherapeuticTelomir PharmaceuticalsTechno Medical PCLTempest TherapeuticsTechno Medica CoAll Stocks A–Z →